Clinical trial
PET Neuroimaging of [11C]Mirtazapine
NCT00288782 · University of Aarhus, Other · Completed
Key facts
| NCT number | NCT00288782 |
|---|---|
| Title | PET Neuroimaging of [11C]Mirtazapine |
| Official title | Receptor Occupancy Determined by PET Neuroimaging of [11C]Mirtazapine in Healthy Humans |
| Lead sponsor | University of Aarhus, Other |
| Collaborators | The Danish Medical Research Council Fund for Advancement of Medical Science Max Woerzner's Research Award |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Mental Disorders, Mood Disorders, Affective Disorders, Depressive Disorders |
| Intervention type | Drug |
| Interventions | Mirtazapine |
| Enrollment | 24 |
| Start date | Feb 1, 2006 |
| Completion | Apr 1, 2007 |
| First posted | Feb 8, 2006 |
| Last update posted | Apr 19, 2007 |
| Countries | Denmark |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: